150 related articles for article (PubMed ID: 21584951)
1. Visualization of human immunodeficiency virus protease inhibition using a novel Förster resonance energy transfer molecular probe.
Jin S; Ellis E; Veetil JV; Yao H; Ye K
Biotechnol Prog; 2011 Jul; 27(4):1107-14. PubMed ID: 21584951
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of probe signal for screening of HIV-1 protease inhibitors in living cells.
Yao H; Jin S
Sensors (Basel); 2012 Dec; 12(12):16759-70. PubMed ID: 23223077
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of in vivo HIV protease activity using genetically engineered QD-based FRET probes.
Cella LN; Biswas P; Yates MV; Mulchandani A; Chen W
Biotechnol Bioeng; 2014 Jun; 111(6):1082-7. PubMed ID: 24473897
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive high-throughput single-cell analysis of HIV protease activity using ratiometric flow cytometry.
Gaber R; Majerle A; Jerala R; Benčina M
Sensors (Basel); 2013 Nov; 13(12):16330-46. PubMed ID: 24287545
[TBL] [Abstract][Full Text] [Related]
5. Development of A Fission Yeast Cell-Based Platform for High Throughput Screening of HIV-1 Protease Inhibitors.
Benko Z; Zhang J; Zhao RY
Curr HIV Res; 2019; 17(6):429-440. PubMed ID: 31782368
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.
Koh Y; Matsumi S; Das D; Amano M; Davis DA; Li J; Leschenko S; Baldridge A; Shioda T; Yarchoan R; Ghosh AK; Mitsuya H
J Biol Chem; 2007 Sep; 282(39):28709-28720. PubMed ID: 17635930
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of inhibition of the retroviral protease by a Rous sarcoma virus peptide substrate representing the cleavage site between the gag p2 and p10 proteins.
Cameron CE; Grinde B; Jentoft J; Leis J; Weber IT; Copeland TD; Wlodawer A
J Biol Chem; 1992 Nov; 267(33):23735-41. PubMed ID: 1331099
[TBL] [Abstract][Full Text] [Related]
8. An improved labeling strategy enables automated detection of single-virus fusion and assessment of HIV-1 protease activity in single virions.
Sood C; Francis AC; Desai TM; Melikyan GB
J Biol Chem; 2017 Dec; 292(49):20196-20207. PubMed ID: 29046351
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence resonance energy transfer-based assay for characterization of hepatitis C virus NS3-4A protease activity in live cells.
Sabariegos R; Picazo F; Domingo B; Franco S; Martinez MA; Llopis J
Antimicrob Agents Chemother; 2009 Feb; 53(2):728-34. PubMed ID: 19064890
[TBL] [Abstract][Full Text] [Related]
10. A quantum-dot based protein module for in vivo monitoring of protease activity through fluorescence resonance energy transfer.
Biswas P; Cella LN; Kang SH; Mulchandani A; Yates MV; Chen W
Chem Commun (Camb); 2011 May; 47(18):5259-61. PubMed ID: 21445447
[TBL] [Abstract][Full Text] [Related]
11. Quantitative FRET analysis with the EGFP-mCherry fluorescent protein pair.
Albertazzi L; Arosio D; Marchetti L; Ricci F; Beltram F
Photochem Photobiol; 2009; 85(1):287-97. PubMed ID: 18764891
[TBL] [Abstract][Full Text] [Related]
12. Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.
Lindsten K; Uhlíková T; Konvalinka J; Masucci MG; Dantuma NP
Antimicrob Agents Chemother; 2001 Sep; 45(9):2616-22. PubMed ID: 11502538
[TBL] [Abstract][Full Text] [Related]
13. Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass Spectrometry.
Meng J; Lai MT; Munshi V; Grobler J; McCauley J; Zuck P; Johnson EN; Uebele VN; Hermes JD; Adam GC
J Biomol Screen; 2015 Jun; 20(5):606-15. PubMed ID: 25681434
[TBL] [Abstract][Full Text] [Related]
14. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
[TBL] [Abstract][Full Text] [Related]
15. Measurement of two caspase activities simultaneously in living cells by a novel dual FRET fluorescent indicator probe.
Wu X; Simone J; Hewgill D; Siegel R; Lipsky PE; He L
Cytometry A; 2006 Jun; 69(6):477-86. PubMed ID: 16683263
[TBL] [Abstract][Full Text] [Related]
16. A cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease.
Breuer S; Sepulveda H; Chen Y; Trotter J; Torbett BE
Biochemistry; 2011 May; 50(20):4371-81. PubMed ID: 21452835
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a new cell line inducibly expressing HIV-1 protease for performing safe and highly sensitive screening of HIV protease inhibitors.
Fuse T; Watanabe K; Kitazato K; Kobayashi N
Microbes Infect; 2006 Jun; 8(7):1783-9. PubMed ID: 16815068
[TBL] [Abstract][Full Text] [Related]
18. Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to I50V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro.
Maguire MF; Guinea R; Griffin P; Macmanus S; Elston RC; Wolfram J; Richards N; Hanlon MH; Porter DJ; Wrin T; Parkin N; Tisdale M; Furfine E; Petropoulos C; Snowden BW; Kleim JP
J Virol; 2002 Aug; 76(15):7398-406. PubMed ID: 12097552
[TBL] [Abstract][Full Text] [Related]
19. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
[TBL] [Abstract][Full Text] [Related]
20. A modular system to evaluate the efficacy of protease inhibitors against HIV-2.
Mahdi M; Matúz K; Tóth F; Tőzsér J
PLoS One; 2014; 9(11):e113221. PubMed ID: 25419967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
